Technology and Heart Failure Therapeutics (THT) is sponsored by the Cardiovascular Research Foundation (CRF) and partially funded through educational grants from commercial supporters. This program is made possible in part by the educational grant support of our industry colleagues who, like CRF, are dedicated to educating medical professionals and the public to enhance patient outcomes. CRF gratefully acknowledges the educational grant support from the following:
Boehringer Ingelheim & Lilly Alliance
Boston Scientific Corporation
Revamp Medical Ltd.
Terumo Medical Corporation